BROADWOOD PARTNERS, L.P. - 12 Nov 2025 SCHEDULE 13D/A Report for Lineage Cell Therapeutics, Inc. Common shares (LCTX)

Filing Manager
BROADWOOD PARTNERS, L.P.
Reporting Manager
NEAL C. BRADSHER
Security
Lineage Cell Therapeutics, Inc. Common shares
Symbol
LCTX
Shares outstanding
250,425,788 shares
Disclosed Ownership
57,848,357 shares
Ownership
23.1%
Form type
SCHEDULE 13D/A
Filing time
14 Nov 2025, 18:12:22 UTC
Date of event
12 Nov 2025
Previous filing
28 Jan 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BROADWOOD PARTNERS, L.P. 23% 57,455,729 0 57,455,729 By /s/ Neal C. Bradsher* By Neal C. Bradsher/President of Broadwood Capital Inc. 0001278386
BROADWOOD CAPITAL, INC. 23% 57,455,729 0 57,455,729 By /s/ Neal C. Bradsher* By Neal C. Bradsher/President 0001278387
NEAL C. BRADSHER 23.1% 57,848,357 392,628 57,455,729 By /s/ Neal C. Bradsher* By Neal C. Bradsher 0001278388